Sian Bigora - 11 Apr 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Development Officer
Signature
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
11 Apr 2025
Net transactions value
-$1,364
Form type
4
Filing time
11 Apr 2025, 17:17:49 UTC
Previous filing
02 Aug 2024
Next filing
18 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +15,059 +69% 36,937 01 Apr 2025 Direct F1
transaction PCSA Common Stock Tax liability $1,364 -3,311 -9% $0.4120 33,626 01 Apr 2025 Direct
holding PCSA Common Stock 6,668 11 Apr 2025 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.